Genomics and Multi-Omics to Guide Clinical Management in Thyroid Cancer

Abstract excerpt

Thyroid cancer comprises a biologically diverse group of tumors initiated by a limited number of recurrent driver alterations, with additional molecular events promoting dedifferentiation, therapeutic resistance, and aggressive clinical behavior. Advances in tumor sequencing have clarified the molecular architecture of papillary, follicular, oncocytic, poorly differentiated, anaplastic, and medullary thyroid...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Ferroptosis and cancer prognosis
• Share to Thyroid Cancer Diagnosis and Treatment
• Share to Thyroid Disorders and Treatments